Bristol-Myers Squibb Company (ETR: BRM)
Germany
· Delayed Price · Currency is EUR
55.24
+0.04 (0.07%)
Nov 21, 2024, 5:35 PM CET
BRM Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2023. The number of employees decreased by 200 or -0.58% compared to the previous year.
Employees
34,100
Change (1Y)
-200
Growth (1Y)
-0.58%
Revenue / Employee
€1,247,221
Profits / Employee
€190,836
Market Cap
112.59B
Employees Chart
Employees History
Bristol-Myers Squibb Company News
- 7 days ago - Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue - Benzinga
- 7 days ago - Bristol Myers gets positive EMA opinion for repotrectinib - Seeking Alpha
- 7 days ago - Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer - Wallstreet:Online
- 7 days ago - Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors - Wallstreet:Online
- 10 days ago - AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio - Benzinga
- 10 days ago - This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 10 days ago - Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock - Benzinga
- 10 days ago - AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say - MarketWatch